183 related articles for article (PubMed ID: 38671941)
21. Urine gastrin-releasing peptide in the first week correlates with bronchopulmonary dysplasia and post-prematurity respiratory disease.
Voynow JA; Fisher K; Sunday ME; Cotten CM; Hamvas A; Hendricks-Muñoz KD; Poindexter BB; Pryhuber GS; Ren CL; Ryan RM; Sharp JK; Young SP; Zhang H; Greenberg RG; Herring AH; Davis SD
Pediatr Pulmonol; 2020 Apr; 55(4):899-908. PubMed ID: 31995668
[TBL] [Abstract][Full Text] [Related]
22. Protein adductomics: A comprehensive analysis of protein modifications by electrophiles.
Shibata T; Uchida K
Free Radic Biol Med; 2019 Nov; 144():218-222. PubMed ID: 30853395
[TBL] [Abstract][Full Text] [Related]
23. Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia.
Banks BA; Ischiropoulos H; McClelland M; Ballard PL; Ballard RA
Pediatrics; 1998 May; 101(5):870-4. PubMed ID: 9565417
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor levels and bronchopulmonary dysplasia in preterm infants.
Mariduena J; Ramagopal M; Hiatt M; Chandra S; Laumbach R; Hegyi T
J Matern Fetal Neonatal Med; 2022 Apr; 35(8):1517-1522. PubMed ID: 32366142
[TBL] [Abstract][Full Text] [Related]
25. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia.
Misra R; Shah S; Fowell D; Wang H; Scheible K; Misra S; Huyck H; Wyman C; Ryan RM; Reynolds AM; Mariani T; Katzman PJ; Pryhuber GS
Hum Immunol; 2015 May; 76(5):329-338. PubMed ID: 25797206
[TBL] [Abstract][Full Text] [Related]
26. Components of the antepartum, intrapartum, and postpartum exposome impact on distinct short-term adverse neonatal outcomes of premature infants: A prospective cohort study.
Nayeri UA; Buhimschi CS; Zhao G; Buhimschi IA; Bhandari V
PLoS One; 2018; 13(12):e0207298. PubMed ID: 30517142
[TBL] [Abstract][Full Text] [Related]
27. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
28. Global Discovery and Temporal Changes of Human Albumin Modifications by Pan-Protein Adductomics: Initial Application to Air Pollution Exposure.
Smith JW; O'Meally RN; Burke SM; Ng DK; Chen JG; Kensler TW; Groopman JD; Cole RN
J Am Soc Mass Spectrom; 2023 Apr; 34(4):595-607. PubMed ID: 36939690
[TBL] [Abstract][Full Text] [Related]
29. Early metabolic markers as predictors of respiratory complications in preterm infants with bronchopulmonary dysplasia.
You Y; Wang L; Liu C; Wang X; Zhou L; Zhang Y; Xia H
Early Hum Dev; 2024 Mar; 190():105950. PubMed ID: 38301336
[TBL] [Abstract][Full Text] [Related]
30. Adductomics Pipeline for Untargeted Analysis of Modifications to Cys34 of Human Serum Albumin.
Grigoryan H; Edmands W; Lu SS; Yano Y; Regazzoni L; Iavarone AT; Williams ER; Rappaport SM
Anal Chem; 2016 Nov; 88(21):10504-10512. PubMed ID: 27684351
[TBL] [Abstract][Full Text] [Related]
31. Serum cytokine concentrations, chorioamnionitis and the onset of bronchopulmonary dysplasia in premature infants.
Kaneko M; Sato M; Ogasawara K; Imamura T; Hashimoto K; Momoi N; Hosoya M
J Neonatal Perinatal Med; 2017; 10(2):147-155. PubMed ID: 28409755
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D and bronchopulmonary dysplasia in preterm infants.
Joung KE; Burris HH; Van Marter LJ; McElrath TF; Michael Z; Tabatabai P; Litonjua AA; Weiss ST; Christou H
J Perinatol; 2016 Oct; 36(10):878-82. PubMed ID: 27467562
[TBL] [Abstract][Full Text] [Related]
33. Blood cytokines during the perinatal period in very preterm infants: relationship of inflammatory response and bronchopulmonary dysplasia.
Paananen R; Husa AK; Vuolteenaho R; Herva R; Kaukola T; Hallman M
J Pediatr; 2009 Jan; 154(1):39-43.e3. PubMed ID: 18760808
[TBL] [Abstract][Full Text] [Related]
34. Association of increased cord blood soluble endoglin with the development of bronchopulmonary dysplasia in preterm infants with maternal preeclampsia.
Kim DH; Shin SH; Kim EK; Kim HS
Pregnancy Hypertens; 2018 Jul; 13():148-153. PubMed ID: 30177044
[TBL] [Abstract][Full Text] [Related]
35. Differences in clinical and laboratory biomarkers for short and long-term respiratory outcomes in preterm neonates.
Parad RB; Breeze JL; Terrin N; Rogers LK; Salafia CM; Greenough A; Davis JM
Pediatr Pulmonol; 2021 Dec; 56(12):3847-3856. PubMed ID: 34437765
[TBL] [Abstract][Full Text] [Related]
36. CircRNA, lncRNA, and mRNA profiles of umbilical cord blood exosomes from preterm newborns showing bronchopulmonary dysplasia.
Wang Y; Wang X; Xu Q; Yin J; Wang H; Zhang L
Eur J Pediatr; 2022 Sep; 181(9):3345-3365. PubMed ID: 35790551
[TBL] [Abstract][Full Text] [Related]
37. Prospective epigenome and transcriptome analyses of cord and peripheral blood from preterm infants at risk of bronchopulmonary dysplasia.
Cho HY; Wang X; Campbell MR; Panduri V; Coviello S; Caballero MT; Bennett BD; Kleeberger SR; Polack FP; Ofman G; Bell DA
Sci Rep; 2023 Jul; 13(1):12262. PubMed ID: 37507442
[TBL] [Abstract][Full Text] [Related]
38. Early clinical markers for the development of bronchopulmonary dysplasia: soluble E-Selectin and ICAM-1.
Ramsay PL; O'Brian Smith E; Hegemier S; Welty SE
Pediatrics; 1998 Oct; 102(4 Pt 1):927-32. PubMed ID: 9755267
[TBL] [Abstract][Full Text] [Related]
39. Identifying Risk Factors Shared by Bronchopulmonary Dysplasia, Severe Retinopathy, and Cystic Periventricular Leukomalacia in Very Preterm Infants for Targeted Intervention.
Wang LW; Lin YC; Wang ST; Huang CC;
Neonatology; 2018; 114(1):17-24. PubMed ID: 29621770
[TBL] [Abstract][Full Text] [Related]
40. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
